Edition:
United States

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

149.00SEK
11 Dec 2018
Change (% chg)

3.00kr (+2.05%)
Prev Close
146.00kr
Open
147.80kr
Day's High
151.00kr
Day's Low
147.40kr
Volume
44,848
Avg. Vol
104,432
52-wk High
209.00kr
52-wk Low
73.20kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 76.00 228.00 0.00 0.00
Earnings (per share)
Year Ending Dec-18 3 -9.88 -9.33 -10.43 -6.72
Year Ending Dec-19 3 -7.48 -4.91 -8.82 -5.22
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.37 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 4.74 15.60 5.12
Price to Tangible Book (MRQ) 4.74 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions -- 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -41.99 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 9.54 5.42 3.11
LT Debt to Equity (MRQ) 0.00 33.58 11.47
Total Debt to Equity (MRQ) 0.00 35.41 15.63
Interest Coverage (TTM) -- -152.90 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.20
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.72 11.83
Operating Margin (TTM) -- -728.64 4.90
Operating Margin - 5 Yr. Avg. -- -526.20 7.44
Pre-Tax Margin (TTM) -- -694.91 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.69 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.51 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,735 898,898,415
Net Income/Employee (TTM) -22,784,650 2,194,099 106,547,429
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.83 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -76.13 0.29 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -76.18 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -114.56 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncopeptides AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -- 71 57
13 Week -1.17 -- 93 61
26 Week 43.67 -- 99 81
52 Week -- -- -- 47
YTD -- -- -- 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.76%
# of Holders: 40
Total Shares Held: 35,169,488
3 Mo. Net Change: -1,280,012
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 6
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.